Table 1.
Baseline characteristics at the time of diagnosis of all patients
| Characteristics | Data (n = 558) |
|---|---|
| Male sex, n (%) | 358 (64.2) |
| Age, median (IQR) | 48 (37–57) |
| Clinical and laboratory features | |
| Systolic BP (mmHg), median (IQR) | 130 (120–140) |
| Diastolic BP (mmHg), median (IQR) | 80 (75–90) |
| Hemoglobin (g/dl), mean ± SD | 13.2 ± 1.9 |
| Serum creatinine (mg/dl), median (IQR) | 0.8 (0.6–1.1) |
| eGFR (ml/min/1.73 m2), median (IQR) | 100.6 (76.2-117.1) |
| Serum albumin (g/dl), median (IQR) | 2.5 (2–3) |
| Total cholesterol (mg/dl), median (IQR) | 294.5 (239–369) |
| Proteinuria (mg/day), median (IQR) | 7100 (4500–10593) |
| Pathological features | |
| Percentage of sclerotic glomeruli, median (IQR) | 4.35 (0-13.04) |
| Interstitial fibrosis, n (%) | |
| None | 320 (57.3) |
| Mild | 201 (36) |
| Moderate | 27 (4.8) |
| Severe | 10 (1.8) |
| Tubular atrophy, n (%) | |
| None | 302 (54.1) |
| Mild | 220 (39.4) |
| Moderate | 27 (4.8) |
| Severe | 9 (1.6) |
BP Blood pressure, eGFR Estimated glomerular filtration rate, IQR Interquartile range, SD Standard deviation